Multiple epidermotropic melanoma metastases developing during BRAF and MEK inhibitor therapy
Saved in:
Published in | JAAD Case Reports Vol. 4; no. 2; pp. 129 - 131 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.03.2018
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Author | Orouji, Azadeh Reinhard, Raphael Larribère, Lionel Gebhardt, Christoffer Maurier, Nolwenn Utikal, Jochen |
---|---|
AuthorAffiliation | a Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany b Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany |
AuthorAffiliation_xml | – name: b Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany – name: a Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany |
Author_xml | – sequence: 1 givenname: Raphael surname: Reinhard fullname: Reinhard, Raphael email: raphael.reinhard@umm.de organization: Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany – sequence: 2 givenname: Christoffer surname: Gebhardt fullname: Gebhardt, Christoffer organization: Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany – sequence: 3 givenname: Nolwenn surname: Maurier fullname: Maurier, Nolwenn organization: Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany – sequence: 4 givenname: Lionel surname: Larribère fullname: Larribère, Lionel organization: Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany – sequence: 5 givenname: Azadeh surname: Orouji fullname: Orouji, Azadeh organization: Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany – sequence: 6 givenname: Jochen surname: Utikal fullname: Utikal, Jochen organization: Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29387762$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kW9rFDEQxoNUbK39Ar6Q_QK35u8mARFqabXYIoi-E8JsMnuXZW-zZPcO-u3NeVraN0Jghsw8v8zkeU1OxjQiIW8ZrRllzfu-7oPPNadM19TWlOoX5IwLxVeK8ebkSX5KLua5p5QyJbXQ7BU55VYYrRt-Rn7d74YlTgNWOMWAeZuWnKboqy0OMKYtlGSBuRycq4B7HEp1XFdhlw_h0_fLmwrGUN1ff63iuIltXFKulg1mmB7ekJcdDDNe_I3n5OfN9Y-rL6u7b59vry7vVl6UkVaNkY1RQVpACYprMEZyKzVjVlJugNEuKI3edLq1rVaqtULSFrhpmbQCxDm5PXJDgt5NOW4hP7gE0f25SHntIC_RD-iEQegQLBoGMhgBFBvftA0GrUTQurA-HlnTrt1i8DguGYZn0OeVMW7cOu2d0sYqzgqAHwE-p3nO2D1qGXUH61zvDta5g3WOWlesK6J3T199lPwzqjR8ODZg-cd9xOxmH3H0GGJGv5RF4__4vwHfJa1q |
Cites_doi | 10.1056/NEJMoa1406037 10.1016/j.advms.2014.12.002 10.1097/CMR.0000000000000332 10.1016/S1470-2045(16)30122-X 10.1016/S0140-6736(15)60898-4 10.1097/DSS.0000000000000251 10.1111/j.1365-2133.2006.07333.x 10.1016/j.ejca.2016.02.023 10.1097/DAD.0b013e3181b34a19 |
ContentType | Journal Article |
Copyright | 2017 American Academy of Dermatology, Inc. 2017 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc. 2017 American Academy of Dermatology, Inc. |
Copyright_xml | – notice: 2017 American Academy of Dermatology, Inc. – notice: 2017 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc. 2017 American Academy of Dermatology, Inc. |
DBID | 6I. AAFTH NPM AAYXX CITATION 5PM DOA |
DOI | 10.1016/j.jdcr.2017.09.007 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access PubMed CrossRef PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2352-5126 |
EndPage | 131 |
ExternalDocumentID | oai_doaj_org_article_38eafea9e81a4d83a0e6c6b6ed753d77 10_1016_j_jdcr_2017_09_007 29387762 S2352512617302138 |
Genre | Case Reports |
GroupedDBID | .1- .FO 0R~ 0SF 1P~ 4.4 457 53G 5VS 6I. AACTN AAEDT AAEDW AAFTH AAIKJ AALRI AAXUO ABMAC ACGFS ADBBV ADEZE AEXQZ AFCTW AFRHN AFTJW AGHFR AITUG AJUYK ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS BAWUL BCNDV EBS EJD FDB GROUPED_DOAJ HYE IPNFZ IXB KQ8 M41 M~E NCXOZ O9- OK1 RIG ROL RPM SSZ Z5R AKRWK NPM AAYXX ADVLN CITATION 5PM |
ID | FETCH-LOGICAL-c3547-684685d49ae4a527a88429471194028a10fd57ec8f7b9b755b9340ba28b1493a3 |
IEDL.DBID | RPM |
ISSN | 2352-5126 |
IngestDate | Thu Jul 04 21:05:14 EDT 2024 Tue Sep 17 21:34:29 EDT 2024 Fri Aug 23 00:42:43 EDT 2024 Thu May 23 23:52:27 EDT 2024 Wed May 17 01:04:45 EDT 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | metastases targeted therapy melanoma MEK BRAF |
Language | English |
License | This is an open access article under the CC BY-NC-ND license. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3547-684685d49ae4a527a88429471194028a10fd57ec8f7b9b755b9340ba28b1493a3 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789521/ |
PMID | 29387762 |
PageCount | 3 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_38eafea9e81a4d83a0e6c6b6ed753d77 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5789521 crossref_primary_10_1016_j_jdcr_2017_09_007 pubmed_primary_29387762 elsevier_sciencedirect_doi_10_1016_j_jdcr_2017_09_007 |
PublicationCentury | 2000 |
PublicationDate | 2018-03-01 |
PublicationDateYYYYMMDD | 2018-03-01 |
PublicationDate_xml | – month: 03 year: 2018 text: 2018-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | JAAD Case Reports |
PublicationTitleAlternate | JAAD Case Rep |
PublicationYear | 2018 |
Publisher | Elsevier Inc Elsevier |
Publisher_xml | – name: Elsevier Inc – name: Elsevier |
References | Roesch, Paschen, Landsberg, Helfrich, Becker, Schadendorf (bib5) 2016; 59 Van Jarwaarde, Wessels, Nieweg, Wouters, van der Hage (bib9) 2015; 41 Ascierto, McArthur, Dréno (bib1) 2016; 17 Long, Stroyakovskiy, Gogas (bib3) 2014; 371 Tas, Erturk (bib6) 2017; 27 Utikal, Zimpfer, Thoelke (bib8) 2006; 155 Stadler, Weina, Gebhardt, Utikal (bib4) 2015; 60 Plaza, Torres-Cabala, Evans, Diwan, Suster, Prieto (bib7) 2010; 32 Long, Stroyakovskiy, Gogas (bib2) 2015; 386 Tas (10.1016/j.jdcr.2017.09.007_bib6) 2017; 27 Ascierto (10.1016/j.jdcr.2017.09.007_bib1) 2016; 17 Plaza (10.1016/j.jdcr.2017.09.007_bib7) 2010; 32 Stadler (10.1016/j.jdcr.2017.09.007_bib4) 2015; 60 Utikal (10.1016/j.jdcr.2017.09.007_bib8) 2006; 155 Roesch (10.1016/j.jdcr.2017.09.007_bib5) 2016; 59 Long (10.1016/j.jdcr.2017.09.007_bib2) 2015; 386 Long (10.1016/j.jdcr.2017.09.007_bib3) 2014; 371 Van Jarwaarde (10.1016/j.jdcr.2017.09.007_bib9) 2015; 41 |
References_xml | – volume: 41 start-page: 78 year: 2015 end-page: 82 ident: bib9 article-title: CO2 laser treatment for regional cutaneous malignant melanoma metastases publication-title: Dermatol Surg contributor: fullname: van der Hage – volume: 371 start-page: 1877 year: 2014 end-page: 1888 ident: bib3 article-title: Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma publication-title: N Engl J Med contributor: fullname: Gogas – volume: 386 start-page: 444 year: 2015 end-page: 451 ident: bib2 article-title: Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial publication-title: Lancet contributor: fullname: Gogas – volume: 155 start-page: 488 year: 2006 end-page: 491 ident: bib8 article-title: Complete remission of multiple satellite and in-transit melanoma metastases after sequential treatment with isolated limb perfusion and topical imiquimod publication-title: Br J Dermatol contributor: fullname: Thoelke – volume: 60 start-page: 83 year: 2015 end-page: 88 ident: bib4 article-title: New therapeutic options for advanced non-resectable malignant melanoma publication-title: Adv Med Sci contributor: fullname: Utikal – volume: 27 start-page: 134 year: 2017 end-page: 139 ident: bib6 article-title: Recurrence behavior in early-stage cutaneous melanoma: pattern, timing, survival, and influencing factors publication-title: Melanoma Res contributor: fullname: Erturk – volume: 17 start-page: 1248 year: 2016 end-page: 1260 ident: bib1 article-title: Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial publication-title: Lancet Oncol contributor: fullname: Dréno – volume: 59 start-page: 109 year: 2016 end-page: 112 ident: bib5 article-title: Phenotypic tumour cell plasticity as a resistance mechanism and therapeutic target in melanoma publication-title: Eur J Cancer contributor: fullname: Schadendorf – volume: 32 start-page: 129 year: 2010 end-page: 136 ident: bib7 article-title: Cutaneous metastases of malignant melanoma: a clinicopathologic study of 192 cases with emphasis on the morphologic spectrum publication-title: Am J Dermatopathol contributor: fullname: Prieto – volume: 371 start-page: 1877 issue: 20 year: 2014 ident: 10.1016/j.jdcr.2017.09.007_bib3 article-title: Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma publication-title: N Engl J Med doi: 10.1056/NEJMoa1406037 contributor: fullname: Long – volume: 60 start-page: 83 issue: 1 year: 2015 ident: 10.1016/j.jdcr.2017.09.007_bib4 article-title: New therapeutic options for advanced non-resectable malignant melanoma publication-title: Adv Med Sci doi: 10.1016/j.advms.2014.12.002 contributor: fullname: Stadler – volume: 27 start-page: 134 issue: 2 year: 2017 ident: 10.1016/j.jdcr.2017.09.007_bib6 article-title: Recurrence behavior in early-stage cutaneous melanoma: pattern, timing, survival, and influencing factors publication-title: Melanoma Res doi: 10.1097/CMR.0000000000000332 contributor: fullname: Tas – volume: 17 start-page: 1248 issue: 9 year: 2016 ident: 10.1016/j.jdcr.2017.09.007_bib1 article-title: Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial publication-title: Lancet Oncol doi: 10.1016/S1470-2045(16)30122-X contributor: fullname: Ascierto – volume: 386 start-page: 444 issue: 9992 year: 2015 ident: 10.1016/j.jdcr.2017.09.007_bib2 article-title: Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(15)60898-4 contributor: fullname: Long – volume: 41 start-page: 78 issue: 1 year: 2015 ident: 10.1016/j.jdcr.2017.09.007_bib9 article-title: CO2 laser treatment for regional cutaneous malignant melanoma metastases publication-title: Dermatol Surg doi: 10.1097/DSS.0000000000000251 contributor: fullname: Van Jarwaarde – volume: 155 start-page: 488 issue: 2 year: 2006 ident: 10.1016/j.jdcr.2017.09.007_bib8 article-title: Complete remission of multiple satellite and in-transit melanoma metastases after sequential treatment with isolated limb perfusion and topical imiquimod publication-title: Br J Dermatol doi: 10.1111/j.1365-2133.2006.07333.x contributor: fullname: Utikal – volume: 59 start-page: 109 year: 2016 ident: 10.1016/j.jdcr.2017.09.007_bib5 article-title: Phenotypic tumour cell plasticity as a resistance mechanism and therapeutic target in melanoma publication-title: Eur J Cancer doi: 10.1016/j.ejca.2016.02.023 contributor: fullname: Roesch – volume: 32 start-page: 129 issue: 2 year: 2010 ident: 10.1016/j.jdcr.2017.09.007_bib7 article-title: Cutaneous metastases of malignant melanoma: a clinicopathologic study of 192 cases with emphasis on the morphologic spectrum publication-title: Am J Dermatopathol doi: 10.1097/DAD.0b013e3181b34a19 contributor: fullname: Plaza |
SSID | ssj0001547371 |
Score | 2.0759823 |
SourceID | doaj pubmedcentral crossref pubmed elsevier |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 129 |
SubjectTerms | BRAF MEK melanoma metastases targeted therapy |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS-wwFA7iQtyIz-tcH2ThToptkzTJUsVBlHEhCi6EcPIoVq4dGecu_PeeNB2dgYt34660pUnP1_R8HzkPQo68UtxWHmVJ6VzGRe4yQFae5VCBLSzLXRnznUc31eU9v3oQD3OtvmJMWCoPnAx3wlSAOoAOqgDuFYM8VK6yVfBItL1MeeSFmBNTKT-YS9aprRIZRoZereozZlJw17N3sRhoIbsip7GX7JxX6or3_9s5LQZOznmi4TpZ6ykkPU1T3yBLod0kK6N-k3yLPI76IEEaYvvXCYIxGb82jr6EP9COXwAPpoCs8C280a-kKZoyFunZ7emQQuvp6OKaNu1TY3HRT2hK1HrfJvfDi7vzy6xvopA5hkbIKiQYSniuIXAQpQQEp9TokgqN0lFBkddeyOBULa22UgirGc8tlMqieGLAdshyO27DLqGy1qj2XFFbiEqLWY1L1gN3KDtC4dmAHM-MaF5TrQwzCyJ7NtHkJprc5NqgyQfkLNr5885Y57o7geibHn3zP_QHRMxQMj1lSFQAH9V8O_ivhOTn8Eh7lETPMCByAeOF-S1eaZunrh43_vQ0sqDfP_FCe2QVp6lSlNs-WZ5O_oYDpD1Te9h94R8BNQAT priority: 102 providerName: Directory of Open Access Journals – databaseName: ScienceDirect Free and Delayed Access Journal dbid: IXB link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELYQh6qXij4oS2nlQ29VtEmcxPaRRaxQq-2hLdIekKzxIyWIza7C9tB_z0ziBSJVHHpLHMe2Zux5JDPfMPbZK1XYyqNbkjuXFGXqEkCrPEmhAptZkbqc8p0X36uLy-LrslzusbNdLgyFVUbZP8j0XlrHlmmk5nTTNNOfOSF5ZoQoLlBRCUr4pRZK4lvOHr-zUHHd3u-i_gm9EHNnhjCvG-8IFjSTPdwpVZV9op96GP9_q6lxCOUTnTQ_YK-iMclPh_W-ZnuhfcNeLOLv8rfsahHDBXmgQrAdsqVbbxrHV-EW2vUK8GILaB_ehTv-mD7Fh9xFPvtxOufQer44_8ab9rqxePw7PqRs_X3HLufnv84uklhOIXECiZBUaGqo0hcaQgFlLgHZlGtUTplGJ1JBlta-lMGpWlptZVlaLYrUQq4sulECxCHbb9dtOGJc1hr9PpfVFsjnElbj4fVQOHRAQubFhH3ZEdFsBtQMswsnuzFEckMkN6k2SPIJmxGdH3oS4nXfsO5-m8hyI1SAOoAOKoPCKwFpqFxlq-DR4fISByl3XDKjDYRDNc9O_n7g5MP0aAApiTpiwuSIx6P1jZ-0zXWPzI3iT6M9dPyfa_nAXuKdGkLcTtj-tvsTPqLNs7Wf-k19D8WS_xA priority: 102 providerName: Elsevier |
Title | Multiple epidermotropic melanoma metastases developing during BRAF and MEK inhibitor therapy |
URI | https://dx.doi.org/10.1016/j.jdcr.2017.09.007 https://www.ncbi.nlm.nih.gov/pubmed/29387762 https://pubmed.ncbi.nlm.nih.gov/PMC5789521 https://doaj.org/article/38eafea9e81a4d83a0e6c6b6ed753d77 |
Volume | 4 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZJCqWX0ne3j0WH3oqztiVb0jG7ZElbnJbSwFIKZvRw4pD1Ls72kH-fkWWnMZQeejHGD2mYGTHz2d-MCPlgpeQ6twhLUmMinsUmAszKoxhy0IlmsUl9vXNxmp-c8c-rbLVHsqEWpiPtG10fNlfrw6a-6LiV27WZDTyx2bdigV6mMOzM9sm-YOweRA-lwVwwkfQFMoHLdWmN7_2ZiK6naex33sMwJ4XI01E86tr2_z0sjSmT92LQ8gl53CeP9CgI-ZTsueYZeVj0v8efk19FTw-kzm_82qIZ2s22NnTtrqDZrAFPdoD54LW7pn_KpWioVaTz70dLCo2lxfEXWjcXtcbl3tJQonXzgpwtj38sTqJ--4TIMNRBlGNqITPLFTgOWSoAzZIqDEaJQtAoIYkrmwlnZCW00iLLtGI81pBKjbCJAXtJDppN414TKiqFOM8klQaPsZhWuFgtcIOAwyWWTcjHQYnlNnTJKAf62GXptV967ZexKlH7EzL3er570ne47i5s2vOyt3PJpIPKgXIyAW4lg9jlJte5swiwrMBBssFKZZ8shCQAh6r_OfmrYMm76QdPmBAxsvFIvvEddMyuE3fviG_--8235BHKJgOp7R052LW_3XvMcnZ62n0dwOOn1XxKHpwuVl9_TjtPvwWGXgEm |
link.rule.ids | 230,315,733,786,790,870,891,2115,3525,27957,27958,45909,53827,53829 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkaAXxJvl6QM3FG0S27F97FZdbWnTA7TSHpCs8SM0Fc2u0u2Bf884ybaNhDhwi-z4oRl7Zr5kHoR89kpxW3iEJblzCRepSwCt8iSFAmxmWeryGO9cnhaLc_51KZY75GAbCxPdKgfZ38v0TloPLdOBmtN1XU-_5zGTZxYzijNUVEw9IA-50Gk82kfL2d2HllhdtwNecUASRwzBM72f16V3MS9oJrt8p7Gs7D0F1eXx_7ueGvtQ3lNK86fkyWBN0v1-w8_ITmiek0fl8L_8BflRDv6CNMRKsC3ypV2ta0evwi9oVleADxtAA_E6XNO7-CnaBy_S2bf9OYXG0_LwmNbNRW3x_re0j9n6_ZKczw_PDhbJUE8hcQyJkBRoayjhuYbAQeQSkE-5Ru2UaUSRCrK08kIGpypptZVCWM14aiFXFnEUA_aK7DarJrwhVFYagZ_LKgsRdDGr8fZ64A4RSMg8m5AvWyKadZ82w2z9yS5NJLmJJDepNkjyCZlFOt--GVNedw2r9qcZeG6YClAF0EFlwL1ikIbCFbYIHhGXlziJ2HLJjE4QTlX_c_HXPSdvl0cLSElUEhMiRzwe7W_c09QXXWpulH8aDaK3_7mXT-Tx4qw8MSdHp8fvyB72qN7f7T3Z3bQ34QMaQBv7sTvgfwCw_gJG |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagSBUX3rQLFHzghrKbxElsH_taFUqqClGpQkjW-JE2pZtdpdsD_HomcdJuKsShtyhxHNsz9synfDNDyEcrRKIzi7AkNiZI0tAEgF55EEIGOtIsNHET75wfZQcnyZfT9HSl1FdL2je6HFeXs3FVnrfcysXMTHqe2OQ430Utk2h2JgtbTB6SR7hnY7kC1H2AcMIZj7owGc_ourCmyQAa8TazadjU30NjJzjP4oFVapP3_9s4DYmTK5Zo-pT86OfgCSi_xtdLPTZ_7qR3vNckn5EnnX9Kt32T5-SBq16Q9bz7A_-S_Mw7BiJ1TW3ZGiVdzxeloTN3CdV8BnixBHQ5r9wVvY3Ioj4cku58255SqCzN9w9pWZ2XGk-UmvoosN-vyMl0__vuQdBVaAgMwwUOMvReRGoTCS6BNOaAko8l2rtIIi4VEIWFTbkzouBaap6mWrIk1BALjciMAXtN1qp55TYJ5YVEKGmiQkMD45iWeB5YSAxiGhdZNiKfegmphU_EoXqG2oVqRKsa0apQKhTtiOw0Qrxp2STRbm_M6zPVrbJiwkHhQDoRQWIFg9BlJtOZs4jhLMdO0l4FVOePeD8Duyr_-_ENryY3n-_VbET4QIEG4xs-QbVok313avDm3m9-IOvHe1P19fPR4VvyGIcpPIXuHVlb1tduC32qpX7f7p6_v7Yh9Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Multiple+epidermotropic+melanoma+metastases+developing+during+BRAF+and+MEK+inhibitor+therapy&rft.jtitle=JAAD+Case+Reports&rft.au=Reinhard%2C+Raphael&rft.au=Gebhardt%2C+Christoffer&rft.au=Maurier%2C+Nolwenn&rft.au=Larrib%C3%A8re%2C+Lionel&rft.date=2018-03-01&rft.issn=2352-5126&rft.eissn=2352-5126&rft.volume=4&rft.issue=2&rft.spage=129&rft.epage=131&rft_id=info:doi/10.1016%2Fj.jdcr.2017.09.007&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_jdcr_2017_09_007 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2352-5126&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2352-5126&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2352-5126&client=summon |